25 days ago
BMRN
AnalystsMohit BansalMohit Bansal's Stock Forecasts
AnalystsMohit Bansal
Analyst Ranking
Top 9%
#410 out of 4587 analysts
Average Return
+15.13%
Win Rate
65%41 out of 63
Risk vs Reward
Poor
Good
Mohit Bansal's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avexis IncAVXS | +199.09% | $72.83 | $217.83 | 2017-05-23 - 2018-05-15 | Strong Buy |
Avantor IncAVTR | +175.70% | $10.41 | $28.70 | 2020-03-20 - 2021-03-19 | Strong Buy |
Eli Lilly & CoLLY | +132.66% | $324.49 | $754.95 | 2023-03-13 - 2024-03-12 | Strong Buy |
Avexis IncAVXS | +127.47% | $95.76 | $217.83 | 2017-10-02 - 2018-05-15 | Strong Buy |
Eli Lilly & CoLLY | +85.30% | $395.86 | $733.51 | 2023-04-28 - 2024-04-26 | Strong Buy |
Mohit Bansal Analyst Color
Get additional color on Mohit Bansal's coverage of popular stocks
a month ago
NBIX
3 months ago
LLY
4 months ago
LLY
7 months ago
PFE
7 months ago
PFE
7 months ago
LLY
9 months ago
LLY
10 months ago
VRTX
a year ago
LLY
a year ago
LLY
a year ago
PFE
a year ago
PFE
a year ago
MRK
2 years ago
LLY
2 years ago
PFE
2 years ago
ABBV
2 years ago
MRK
2 years ago
PFE
Mohit Bansal's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biomarin Pharmaceutical IncBMRN | 2 | Strong Buy | $110.00 | +41.83% | Maintains | 25 days ago |
Neurocrine Biosciences IncNBIX | 7 | Strong Buy | $170.00 | +19.47% | Upgrades | a month ago |
Bristol Myers Squibb CoBMY | 7 | Hold | $52.00 | +18.10% | Maintains | a month ago |
Merck & Co IncMRK | 8 | Hold | $135.00 | +2.90% | Maintains | 2 months ago |
Gilead Sciences IncGILD | 7 | Hold | $78.00 | +15.18% | Maintains | 3 months ago |
Ironwood Pharmaceuticals IncIRWD | 2 | Strong Buy | $14.00 | +116.05% | Maintains | 3 months ago |
Travere Therapeutics IncTVTX | 3 | Hold | $9.00 | +48.51% | Maintains | 3 months ago |
Biogen IncBIIB | 8 | Hold | $240.00 | +4.09% | Downgrades | 3 months ago |
Eli Lilly & CoLLY | 14 | Strong Buy | $825.00 | +7.14% | Maintains | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 7 | Strong Buy | $540.00 | +21.29% | Maintains | 3 months ago |
Pfizer IncPFE | 8 | Hold | $35.00 | +22.21% | Maintains | 7 months ago |
Regeneron Pharmaceuticals IncREGN | 9 | Strong Buy | $980.00 | -0.23% | Maintains | 9 months ago |
Chinook Therapeutics IncKDNY | 1 | Hold | $40.00 | -0.97% | Downgrades | 10 months ago |
Cerevel Therapeutics Holdings IncCERE | 3 | Strong Buy | $30.00 | N/A | Upgrades | a year ago |
Abbvie IncABBV | 3 | Strong Buy | $195.00 | N/A | Maintains | a year ago |
Halozyme Therapeutics IncHALO | 3 | Strong Buy | $48.00 | N/A | Maintains | a year ago |
Amgen IncAMGN | 5 | Strong Buy | $265.00 | N/A | Upgrades | a year ago |
Mineralys Therapeutics IncMLYS | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | a year ago |
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | a year ago |
9 Meters Biopharma IncNMTRQ | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 3 years ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 3 years ago |
Gracell Biotechnologies IncGRCL | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 3 years ago |
Radius Health IncRDUS1 | 1 | Strong Buy | $30.00 | N/A | Maintains | 3 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $175.00 | N/A | Downgrades | 3 years ago |
Shattuck Labs IncSTTK | 1 | Strong Buy | $36.00 | N/A | Initiates Coverage On | 4 years ago |
Myokardia IncMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 4 years ago |
Adaptimmune Therapeutics PLCADAP | 1 | Strong Buy | $5.00 | N/A | Maintains | 4 years ago |
Calithera Biosciences IncCALA | 2 | Strong Buy | $140.00 | N/A | Maintains | 4 years ago |
Avantor IncAVTR | 1 | Strong Buy | $11.00 | N/A | Maintains | 4 years ago |
Audentes Therapeutics IncBOLD1 | 2 | Hold | $28.00 | N/A | Maintains | 5 years ago |
Avexis IncAVXS | 2 | Strong Buy | $116.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.